Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack - blocking the ...

Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, published in the journal Life Science Alliance, allows researchers to study ...

AVA6103 inhibits tumor growth, with complete responses noted in a preclinical treated model engineered with human FAP expression (HEK-FAP) tumors. Increased survival was also shown in this model ...

It targets multiple tumor sites, killing tumor cells while altering the tumor immune microenvironment. This novel therapeutic approach not only facilitates easier administration but also broadens the ...

In the realm of oncology, the concept of 'metabolic rewiring' has expanded beyond aerobic glycolysis to encompass various metabolic strategies that cancer cells employ for survival and progression, ...

Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of ...

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede ...

“We and others have previously observed that alterations in STK11 and KEAP1 can promote an immunosuppressive tumor microenvironment and together might be responsible for half or more of the primary ...

A significant obstacle in treating ovarian cancer is the tumor microenvironment—the complex ecosystem of cells, molecules and ...

All breast cancers aren't the same. A specialized doctor called a pathologist learns about each person's breast cancer by ...

Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, ...